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OBJECTIVES The present study was aimed to evaluate the efficacy of a specific algorithm with continuous
atrial dynamic overdrive pacing to prevent atrial fibrillation (AF) after coronary artery bypass
graft (CABG) surgery.
BACKGROUND Atrial fibrillation occurs in 30% to 40% of patients after cardiac surgery with a peak incidence
on the second day. It still represents a challenge for postoperative prevention and treatment
and may have medical and cost implications.
METHODS Ninety-six consecutive patients undergoing CABG for severe coronary artery disease and in
sinus rhythm without antiarrhythmic therapy on the second postoperative day were
randomized to have or not 24 h of atrial pacing through temporary epicardial wires using a
permanent dynamic overdrive algorithm. Holter ECGs recorded the same day in both groups
were analyzed to detect AF occurrence.
RESULTS No difference was observed in baseline data between the two study groups, particularly for
age, male gender, history of AF, ventricular function, severity of coronary artery disease,
preoperative beta-adrenergic blocking agent therapy or P-wave duration. The incidence of AF
was significantly lower (p 5 0.036) in the paced group (10%) compared with control subjects
(27%). Multivariate analysis showed AF incidence to increase with age (p 5 0.051) but not
in patients with pacing (p 5 0.078). It decreased with a better left ventricular ejection fraction
only in conjunction with atrial pacing (p 5 0.018).
CONCLUSIONS We conclude that continuous atrial pacing with an algorithm for dynamic overdrive reduces
significantly incidence of AF the second day after CABG surgery, particularly in patients with
preserved left ventricular function. (J Am Coll Cardiol 2000;35:1411–5) © 2000 by the
American College of Cardiology
Supraventricular tachyarrhythmias and particularly atrial
fibrillation (AF) represent a common therapeutic challenge
after cardiac surgery. Atrial fibrillation occurs in 30% to 40%
of the cases, with a peak incidence during the second
postoperative day (1). Postsurgical AF can induce hemody-
namic deterioration and increases the risk of stroke or
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ventricular arrhythmias (2,3). Moreover, AF may influence
significantly the costs of surgical procedure due to its high
incidence and its impact on hospital stay (4,5). Many
clinical trials evaluating the preventive efficacy of different
antiarrhythmic drugs have been published. If digitalis (6)
and verapamil (7) are not effective, prophylactic treatment
with beta-adrenergic blocking agents, sotalol or amiodarone
was shown to be useful, but these drugs may be contrain-
dicated in many situations (6–8).
Atrial pacing with an implantable stimulator is one of the
new methods under investigation to prevent recurrences of
AF (9,10). Even though temporary epicardial wires have
been proposed for many years for diagnosis and treatment of
atrial arrhythmias after cardiac surgery (11), their use
coupled with continuous overdrive pacing to prevent post-
coronary artery bypass graft (CABG) AF has not been
evaluated extensively. The aim of our study was to test the
hypothesis that continuous atrial dynamic overdrive pacing
through temporary epicardial wires, performed on the sec-
ond day after surgery, could reduce significantly the inci-
dence of postoperative AF.
From the *Department of Cardiology, †Intensive Care Unit, ‡Cardiovascular
Surgery and §Biostatistics Unit, Universite´ Catholique de Louvain, Cliniques
Universitaires de Mont-Godinne, Yvoir, Belgium. This work was supported by funds
of the Me´ce´nat of the Cardiology Department of Mont-Godinne Hospital.
Manuscript received April 22, 1999; revised manuscript received September 22,
1999, accepted February 2, 2000.
Journal of the American College of Cardiology Vol. 35, No. 6, 2000
© 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00
Published by Elsevier Science Inc. PII S0735-1097(00)00608-2
METHODS
Patient population. Ninety-six consecutive patients un-
dergoing elective CABG surgery for severe symptomatic
coronary artery disease were enrolled in the study on the
basis of a sinus rhythm without any antiarrhythmic drug and
a stable hemodynamic status the second day after surgery.
The CABG was performed using single atrial cannulation
and cardiopulmonary bypass. Patients with a permanent
pacemaker, those having atrioventricular conduction abnor-
malities or treated with amiodarone before surgery were
excluded. Treatment with any other antiarrhythmic drug,
beta-blockers or digoxin had to be stopped before CABG.
Preoperative clinical data were obtained from all patients
by reviewing medical records and included age, gender,
history of AF, previous myocardial infarction or cardiac
surgery, and symptoms of heart failure. Left ventricular
ejection fraction (LVEF) was calculated by cine-
angiography and/or transthoracic echocardiography. P-wave
duration was measured from lead II of the preoperative
ECG. Aortic cross-clamp time was noted for each patient.
Eligible patients gave their informed consent orally and
were randomized between atrial stimulation (group 1) and
no stimulation (group 2). The study was approved by the
Ethics Committee of our institution.
Study protocol. Two sets of epicardial wire electrodes
(Medtronic model 6500; Medtronic Inc.; Minneapolis, Min-
nesota) attached, respectively, on the right ventricle and on the
high right atrium, near the sinus node, were implanted in all
patients as a routine practice in our institution.
The second day after surgery, an external pacemaker
(Harmony; Vitatron Inc.; Dieren, The Netherlands) was
connected to the atrial wires for 24 h continuous atrial
pacing in AAI mode with a lower rate of 80 beats/min. A
specific algorithm for dynamic overdrive was programmed,
allowing the pacemaker to always stimulate just above the
patient’s own rhythm, to an upper limit of 125 beats/min.
Thus, when a spontaneous beat is sensed, the algorithm
increases the heart rate by shortening its escape interval by
50 ms. The pacemaker then increments gradually the
interval by 5 ms per stimulus, reducing heart rate until the
lower rate limit is reached or a new spontaneous beat is
detected (Fig. 1).
A 24-h ECG recording was performed the same day in
both patients with pacing and control patients with a Holter
recorder (Avionics; Del Mar Inc.). The primary end point of
the study was the occurrence, on the Holter ECG, of an
episode of AF, considered as significant when sustained for
at least 15 min. When necessary, AF was treated with
antiarrhythmic drugs, without interrupting atrial pacing. A
continuous infusion of amiodarone was used in most of the
Abbreviations and Acronyms
AF 5 atrial fibrillation
APB 5 atrial premature beats
CABG 5 coronary artery bypass graft
LVEF 5 left ventricular ejection fraction
PAP 5 pulmonary artery pressure
PCWP 5 pulmonary capillary wedge pressure
Figure 1. The dynamic overdrive pacing algorithm allows atrial pacing in the AAI mode, always just above the patient’s own rhythm.
When a premature beat is sensed, the algorithm increases the heart rate by shortening its escape interval by 50 ms to a programmed upper
rate limit. The pacing cycle length is then gradually increased by 5 ms per stimulus until the lower rate limit is reached or another
spontaneous beat is sensed.
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patients, at a dose of 900 to 1,200 mg/24 h. In addition,
patients were monitored with telemetry and with a Swan-
Ganz catheter for hemodynamic parameters. The ECG
tracings were analyzed for arrhythmia with an analyzing
system (Del Mar Avionics) and reviewed by the same
cardiologist.
Statistical analysis. Results are presented as mean 6 SD or
proportions (percents). Categorical and numerical variables
were compared between the two groups using chi-square or
Wilcoxon rank sum test as appropriate. The influence of
various factors on the onset of AF was studied by logistic
regression with backward selection of variables by likelihood
ratio test. The significance of selected parameters in the
final model was assessed by the Wald test. All statistical
tests are two-tailed. A p value ,0.05 was required for
statistical significance.
RESULTS
Patient characteristics. A total of 96 consecutive patients
(73 men) with a mean (6 SD) age of 66 6 9 years (range,
39 to 80 years) have been enrolled in the study and were
randomized to group 1 for atrial overdrive pacing (n 5 48)
or to group 2 (n 5 48) as control. The mean (6 SD) LVEF
was 57 6 14% and only 7.4% of the patients had a prior
episode of heart failure. Beta-blockers were used preopera-
tively in 62% of the patients of group 1 and in 56% of group
2 (p 5 0.67). No patients were treated with digoxin.
Baseline characteristics of the two study groups are com-
pared in Table 1 and no statistically significant differences
were observed for any parameter.
Holter and ECG data. Significantly fewer patients of group
1 developed AF compared with group 2: 5 of 48 (10%) versus
13 of 48 (27%) (p 5 0.036). However, the duration of AF
episodes did not differ significantly (p 5 0.27) between group
1 (median, 120 min; range, 16 to 780 min) and group 2
(median, 378 min; range, 18 to 800 min).
Preoperative P-wave duration was similar with a mean of
108 6 14 ms for group 1 compared with 103 6 12 ms for
group 2 (p 5 0.07). It was no more different between patients
of both groups developing AF on day 2 after surgery (mean,
107 6 14 ms) and patients not developing AF (mean, 105 6
13 ms) (p 5 0.65). However, P-wave length increased signif-
icantly during atrial pacing (116 6 2 ms) compared with
preoperative values (108 6 2 ms) (p 5 0.003).
As expected, mean (93 6 11 vs. 87 6 11 beats/min; p 5
0.011) and lower (83.5 6 6 vs. 73 6 11 beats/min; p ,
0.001) heart rates, including AF episodes, were higher in
the group with pacing than in the control group, respec-
tively. The maximum rate was only slightly and not signif-
icantly higher in the group with pacemakers (119 6 24
beats/min) compared with control subjects (113 6 18
beats/min) (p 5 0.39).
Hemodynamic data. The mean cardiac index measured on
the second postoperative day did not differ significantly in
both groups (2.96 6 0.48 vs. 2.86 6 0.40 liter/min; p 5
0.42). Furthermore, mean pulmonary artery pressure (PAP:
20 6 4 vs. 21 6 4 mm Hg), pulmonary capillary wedge
pressure (PCWP: 12 6 3 vs. 11 6 2 mm Hg) and central
venous pressure (9 6 3 vs. 9 6 3 mm Hg), were similar in
Table 1. Clinical and Perioperative Characteristics of Paced and Control Groups
Variable (Mean 6 SD)
All Patients
(n 5 96)
Paced
(n 5 48)
Control
(n 5 48)
Preoperative values
Age (yr) 67 6 9 66 6 9 67 6 8
Male gender (%) 76 79 73
Prior myocardial infarction (%) 48 52 44
LVEF (%) 57 6 14 56 6 14 57 6 13
Heart failure symptoms (%) 7 8 6
History of AF (%) 1 2 0
Beta-blocker use (%) 59 62 56
P-wave duration (ms) 105 6 13 108 6 14 103 6 12
Perioperative values
Aortic cross-clamp time (min) 92 6 23 89 6 27 95 6 20
No. of grafts per patient 2.6 6 0.5 2.5 6 0.5 2.6 6 0.5
LIMA (%) 96 98 94
RIMA (%) 78 83 73
Postoperative values
Peak of CPK release 889 6 466 808 6 384 966 6 525
Peak of CPK MB release 39 6 22 41 6 23 37 6 20
Thoracic drains still present (%) 74 77 72
Cardiac index on day 2 (liter/min) 2.91 6 0.44 2.96 6 0.48 2.86 6 0.40
AF 5 atrial fibrillation; CPK 5 creatine phosphokinase; LIMA 5 left mammary artery; LVEF 5 left ventricular ejection
fraction; RIMA 5 right mammary artery.
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group 1 and in group 2, respectively. These parameters did
not differ between AF and non-AF patients of both groups.
During AF episodes, hemodynamics deteriorated signif-
icantly in both groups with an increase of mean PAP (24 6
3 vs. 27 6 4 mm Hg; p 5 0.004) and PCWP (13 6 2 vs.
18 6 3 mm Hg; p , 0.0001) and a decrease of systolic
blood pressure (136 6 22 vs. 116 6 24 mm Hg; p 5 0.015).
Transcutaneous values of oxygen blood saturation also
decreased below 93% in two patients during AF. No patient
needed external electric cardioversion for AF due to hemo-
dynamic compromise.
Initiation of AF. The onset of AF was studied in all
patients. Atrial fibrillation followed an atrial premature beat
(APB) in the 5 patients with pacing as well as in 13 control
subjects, following a postextrasystolic pause in one of latter.
During the 5 min preceding AF episodes, there were ,15
APBs in three patients and .60 in the two others of group
1. In group 2, four patients had ,15 APBs and two others
had .60; seven patients had between 15 and 60 APBs. The
mean coupling interval of APBs was 71% and 68% of the
previous cycle length for group 1 and for group 2, respec-
tively.
Multivariate analysis. In a multivariate analysis, the oc-
currence of AF in all studied patients was adjusted for
different variables: age, LVEF, atrial pacing and their
possible interactions. Thus, AF incidence was found to
increase with age (p 5 0.051), but not in patients with
pacemakers (p 5 0.078). It decreased with a better LVEF,
but only in patients undergoing atrial pacing (p 5 0.018).
However, analysis of the same parameters in each group
separately did not show any significant effect of age on AF
incidence in the group undergoing pacing (p 5 0.89).
Furthermore, when patients with an LVEF .50% were
analyzed, AF occurred in significantly fewer patients of
group 1 (6%) than of group 2 (26%) (p 5 0.016). For
patients with a lower LVEF, the difference was not signif-
icant between group 1 (30%) and group 2 (33%) (p 5 1.0),
suggesting that atrial pacing was more effective with an
LVEF superior to 50%.
DISCUSSION
Atrial fibrillation occurred in 10% of patients with pace-
makers compared with 27% in control subjects during the
24 h of ECG recording performed on the second day after
CABG. The overall incidence is similar to those in recent
series (1,4).
It has been suggested that the pathogenesis of post-
CABG AF is probably multifactorial with abnormal atrial
conduction and a lack of uniformity of atrial repolarization
as a substrate and with different triggers, including su-
praventricular premature contractions, pericarditis, electro-
lyte disorders, cardiopulmonary bypass and cardioplegia.
Atrial ischemia and autonomic disturbances such as an
increase in sympathetic tone after surgery or hypersensitivity
to adrenergic stimulation due to beta-blocker therapy with-
drawal have also been incriminated (12,13).
Many investigators attempted to identify independent clin-
ical and perioperative predictive or precipitating factors of
post-CABG AF. The most important of them seem to be
increasing age, male gender, history of AF, congestive heart
failure or digoxin therapy (1,14). Moreover, prolonged P-wave
duration and serum magnesium (15) or severe right coronary
artery stenosis (16) have also been advocated. In our study,
preoperative P-wave duration did not appear to be a risk factor
for AF occurrence. This is in agreement with Frost et al. (17)
who did not find any influence of P-wave duration on AF
occurrence when adjusted for a patient’s characteristics.
Preventive drug therapy. Several trials focusing on preven-
tive drug therapy for post-CABG AF have been performed.
In their meta-analysis, Kowey et al. (6) and Andrews et al.
(7) found that only the use of beta-blocking agents alone,
even at low doses or combined with digoxin, was the most
effective prophylactic treatment, whereas digoxin used alone
was ineffective. A beneficial effect of sotalol, a beta-blocker
with class III properties, was suggested by some recent series
(18,19) but is still debated (20). Furthermore, these drugs
may be contraindicated in some cases and one may notice
that most of the trials on prevention of postsurgical AF
exclude older patients, those with poor left ventricular
function or pulmonary problems. Thus, some other thera-
peutic options could be of major interest in the prevention
of AF following cardiac surgery.
Prevention of AF by atrial pacing. Prevention of parox-
ysmal AF by continuous pacing has been investigated in
studies involving patients with permanent pacemakers.
However, most of these studies focused on the comparison
of different modes of pacing (e.g., VVI vs. DDD, DDD vs.
DDDR), sites of pacing (e.g., atrial or biatrial pacing)
(10,21) or some specific algorithms. There are some data
concerning the use of temporary epicardial wires for the
diagnosis and the treatment of supraventricular arrhythmias
after cardiac surgery (22).
However, our study is, to our knowledge, the first one
assessing the efficacy of temporary atrial overdrive pacing for
the prevention of post-CABG AF in a larger group of patients
without the adjunction of drugs. For this purpose, we used a
specific algorithm that reacts to APBs and allows permanent
stimulation of the atria just above the patient’s own rhythm.
These two characteristics could be essential for influencing
effectively the electrophysiologic substrate initiating AF. If a
simple overdrive function at a fixed heart rate of 80 to 90
beats/min is used, the heart will be paced only for long period
but without adequate intervention after APBs or during faster
heart rates. In their article, Delfaut et al. (10) suggested that it
was necessary to stimulate the atria .80% of the time to be
effective. Our results support the hypothesis that prevention of
AF probably requires permanent atrial overdrive pacing to
obtain continuous modification of the electrical substrate.
With the specific algorithm we used, an even higher percent-
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age of stimulation, close to 90%, can be achieved. However, in
some patients, factors other than instability of cycle length may
be involved in initiating AF.
Analysis of the number of APBs before AF onset shows
that in the control group with a higher incidence of AF,
there are 7 of 13 patients who had between 15 and 60 APBs.
In contrast, most of the patients in the group with pacing
had either very few or a substantial number of APBs. This
may indicate that dynamic overdrive pacing is best designed
for this category of patients with a moderate number of
APBs.
Role of ventricular function and age. Surprisingly, our
results suggest that atrial dynamic overdrive pacing is less
effective in patients with reduced preoperative LVEF. It has
been suggested that fibrosis, atrial dilatation or structural
changes may play a role in this phenomenon (4). However,
hemodynamic parameters recorded in our patients some
hours before the onset of AF do not seem to have any
predictive value. This could be explained by the fact that
these acute parameters do not reflect the real preoperative
left ventricular function.
Another interesting finding in our study is that dynamic
overdrive pacing was effective in older patients as well as in
younger patients even though age was confirmed as a
significant risk factor for AF occurrence in the whole study
population. This suggests a particular interest of atrial
pacing as preventive treatment of AF in the elderly, com-
pared for example, with beta-blocker therapy that was found
by Fuller et al. (14) to be of little benefit in preventing
postsurgical AF in patients older than 65 years.
Limitations of the study. One limitation of the study is the
monitoring period of atrial arrhythmias that is too short to
assess long-term benefits of dynamic overdrive pacing. There is
also a need for further studies to confirm the lack of efficacy of
prophylactic atrial pacing in patients with low LVEF.
CONCLUSIONS
The use of temporary epicardial wires for continuous atrial
pacing with a specific algorithm for atrial dynamic overdrive
reduces significantly the incidence of AF on the second day
after CABG surgery in the absence of antiarrhythmic
therapy, particularly in patients with normal preoperative
left ventricular function. This technique, in combination
with antiarrhythmic therapy and low energy internal defi-
brillation when necessary, may enhance prevention and
treatment of postoperative AF and could be useful to
decrease hospital stay and thereby reduce costs. Technologic
improvements of next-generation pacemakers could allow
extension of this approach to patients with recurrent AF.
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